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Case report: Multifocal chronic paracoccidioidomycosis in an adult
KAREN ZAPATA, MD1, JANETH VILLANUEVA, MD2, ADRIANA ARRUNÁTEGUI, MD2,
JUANA GABRIELA LÓPEZ, MD1
SUMMARY
Paracoccidioides brasiliensis is the ethiological agent of one of the most prevalent systemic mycosis in Latin America,
where around ten-million individuals are affected. Brazil has the highest incidence but in Venezuela, Colombia, Ecuador, and
Argentina cases have also been reported. We describe a 56-year-old male with a one year history of lip, oral mucosa, and lung
lesions. Granulomas and multinucleated giant cells were observed in histopathological evaluation with haematoxilyn-eosin
stain. Mycologic studies (KOH and Gomori Grocott stain) showed blastoconidias with multiple budding. Serologic tests for
paracoccidioidine were reactive. A diagnosis of chronic multifocal paracoccidioidomycosis was made. Initially, amphotericin
B 0.7 mg/kg per day was started for fifteen days and consecutively itraconazole (400 mg/day) was administered orally with
improvement of skin and lung lesions; however, an important residual fibrosis was observed. The patient was lost to follow
up. We highlight the importance of an early diagnosis and adequate treatment to decrease sequelae in patient quality of life.
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Itraconazole; Complications.
 Colomb Med. 2011; 42: 228-32
Informe de caso: Paracoccidioidomicosis crónica multifocal del adulto
RESUMEN
Paracoccidioides brasiliensis es el agente causal de una de las micosis sistémicas con mayor prevalencia en Latinoamérica.
Existen alrededor de 10 millones de afectados y la mayor incidencia se presenta en Brasil y se han observado casos en
Venezuela, Colombia, Ecuador y Argentina. Se presenta el caso de un hombre de 56 años con lesiones de un año de evolución
en labios, mucosa oral y pulmón. El estudio histopatológico con hematoxilina-eosina informó la presencia de granulomas y
células gigantes multinucleadas. Los estudios micológicos (KOH y tinción de Gomori Grocott) mostraron blastoconidias con
gemación múltiple. Las pruebas serológicas para paracoccidioidina fueron reactivas. Se diagnosticó un caso de
paracoccidioidomicosis multifocal crónica y se inició tratamiento anfotericina B 0.7 mg/kg/día durante 15 días, luego
itraconazol 400 mg diarios. Las lesiones cutáneas y pulmonares mejoraron; sin embargo, presentaba una fibrosis residual
importante en la región oral y no continuó el seguimiento. Se resalta la importancia de realizar un diagnóstico temprano y
disminuir las posibles secuelas que van a repercutir directamente sobre la calidad de vida del paciente.
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Paracoccidioidomycosis is a progressive, systemic
mycosis caused by Paracoccidioides brasiliensis, a
dimorphic fungus found in soils of some regions of
Latin America; mainly between 30º latitude south and
34º latitude north1. The actual frequency is unknown
because it is a not a disease of obligatory report.
CLINICAL CASE
Herein, we present a case of a male patient, 56 years
of age from the city of Pasto and residing in the city of
Cali, Colombia; a street vendor, with a 10-month history
since the apparition of papular lesions on the lips and
gums. These lesions evolved into edemas, deformity,
and ulcerated plaques with exudative crusts that
compromised the whole oral cavity and were associated
to weight loss, pain upon masticating and swallowing,
limitation for opening the mouth and speaking. Then,
verruciform plaques appeared on the second and fifth
fingertips of the right hand and left hand, respectively,
which progressed until revealing necrosis areas
(Photographs 1, 2, and 3). The patient did not present
other associated symptoms or relevant pathological
antecedents.
The patient had an important epidemiological
antecedent, he had emigrated from a wooded region,
where he performed agricultural and carpentry tasks, to
his current place of residence, an urban area located
between coordinates 3º27’00’’N and 76º32’00’’W,
geographically located on the Cauca River with a mean
1000-m altitude above sea level and a temperature of
25ºC.
Complementary histopathological studies and
laboratory studies were requested. Blood tests revealed
homogeneous normochromic normocytic anemia,
leukocytosis with neutrophilia, thrombocytosis, and
the erythrocyte sedimentation rate of 50 mm/h. Renal
function, hepatic function, and electrolytes did not
show alterations. VDRL tests for syphilis and ELISA
tests for HIV were negative, as well as the cutaneous
tuberculin test, the Zielh-Neelsen stain for mycobacteria,
and the Fite Faraco stain. A biopsy was performed of
the lip lesions, which reported multiple-budding
blastoconidia upon direct exam with potassium
hydroxide at 20%. The histopathological study with
hematoxylin-eosin reported epithelium with acantosis
and abundant dermal inflammatory infiltrate with
Photograph 1. Exudative and crusted plaques in
oral cavity with limitation of the mouth opening
Photograph 2. Marked volume increase in
sub-mandibular region
Photograph 3. Necrotic exudative plaque on
fingertip of second finger in the left hand
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formation of granulomas and giant multinucleated cells.
When staining with Gomori-Grocott, multiple budding
blastoconidia were observed (Photograph 4).
The immunodiffusion test was also performed in
agar gel with paracoccidioidine, reactive with one band
of precipitate and the fixation of the complement,
which was reactive to the 1:8 dilution. Thoracic X-ray
revealed dense interstitial infiltrate with reticular zones
in both pulmonary fields (Photograph 5).
Because of the cutaneous and pulmonary compro-
mise, as well as of the oral mucosa, and confirmation
through biopsy, the diagnosis indicated multifocal
Photograph 4. Gomori-Grocott stain with
multiple budding blastoconidia
chronic paracoccidioidomycosis in an adult. Treatment
was begun with amphotericin B 0.7 mg/kg/day (42 mg
daily) for 15 days. Thereafter, treatment continued by
administering itraconazole 200 mg every 12 hours for
three months. This led to the patient presenting
improvement of mucosa and pulmonary lesions;
however, the patient presented marked limitation to
open the mouth, secondary to fibrosis (Photograph 6).
We requested plastic surgery and otolaryngology
evaluation for its multidisciplinary management;
nevertheless, the patient did not continue attending
follow up controls and it has not been possible to
continue assessing his therapeutical response or moni-
tor existing sequelae.
DISCUSSION
Paracoccidioidomycosis is a chronic, granulomatous,
systemic mycosis caused by the P. brasiliensis fungus2,3.
Also called Lutz-Splendore-Almeida disease or South
American blastomicosis, it was described by Adolfo
Lutz in 1908 pseudococcidioidal granuloma; then in
1928, Almeida and Lacaz named the Paracoccidioides
genus and in 1930, Almeida called the fungus Paraco-
ccidioides brasiliensis1.
Thermal dimorphism is an important characteristic
of the fungus, which is found as mold in nature between
4 and 25°C. Its rate of growth is relatively slow and it
seems to present a restricted ability to compete or
Photograph 5. AP X-ray of thorax presented
dense interstitial infiltrate with reticular zones in
both pulmonary fields
Photograph 6. After three months of treatment with
itraconazole, 200 mg every 12 hours; patients
presents marked residual fibrosis
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survive in the presence of the normal microbial flora of
the soil4. A colony provided with short aerial mycelium
was observed with hyaline septate hyphae, scarce
microconidia , and chlamydoconidia. Between 35°C
and 37ºC, it grows as double-walled spherical yeast that
reproduces by multiple budding, giving a «boat rudder»
appearance5.
The habitat is still not well established; however, it
has been isolated in tropical or subtropical regions with
acid soils and temperatures varying between 17 and
24ºC, in altitudes between sea level and 1500 meters,
with a rainfall between 500 and 2500 mm/yearly. In
these environments, the fungus exists as a plant and soil
saprophyte2. The natural reservoir for P. brasiliensis is
still under study, in recent years in several geographic
regions of Brazil and Colombia species of infected
armadillos have been described (Dasypus novem-
cinctus), before these discoveries it was considered that
humans were its only host4.
In Latin America, there are close to 10-million
individuals affected, but only 2% will develop the
disease2. This systemic mycosis has a broad geographic
distribution from Mexico to Argentina. Nevertheless, it
does not occur in Nicaragua, Chile, or Guyana. The
greatest incidence occurs in Brazil; cases have also
been observed in Venezuela, Colombia, Ecuador, and
Argentina2. The rate of incidence in Colombia between
1980 and 1999 was of 0.1 to 2.4 per 1’000,000
inhabitants, Antioquia, Santander, Cundinamarca, Meta,
Caldas, Boyacá, and Tolima were identified as endemic
departments -all are located in the country’s central
Eastern Andean region and the Magdalena River in
Sierra Nevada of Santa Marta6. The distribution of
paracoccidioidomycosis is heterogeneous in Colom-
bia; in the case we are presenting, the patient was from
the country’s southwestern region, which is not within
the endemic regions. But adequately diagnosing cases
is important to be able to detect any change that may be
presented in the region.
The rate of mortality in Brazil is of 1.45/1,000,000
inhabitants7. It is most frequent in males with ratio of
10-15 to 1 with respect to females; in children an equal
distribution is noted in both genders. Age ranges from
childhood and adolescence to 30 to 50 years of age,
where it may reach its greatest incidence; with 30 to 50
years being a productive age in life, thereby it bears a
high social and economic impact. Although the entry
route of the fungus is still a controversial issue, in most
cases humans are mainly susceptible to infection by
conidia inhalation.
The main risk factors for acquiring the disease
involve activities related with the manipulation of
contaminated soils or organic matter. Primo-infection
usually occurs during the first decades of life with an
incidence peak between 10 and 20 years of age, with the
most frequent clinical manifestations between 30 and
50 years of age due to reactivation of a latent focus,
which may develop, because of multiple factors that
determine the immune status of the host like: age, use
of immunosuppressive medications, and concomitant
disease. The incubation period may last from some
weeks to 60 years.
It is important to investigate the epidemiological
antecedents, work activities, and migratory patterns
because, for example, in our case the patient had
performed agricultural tasks several years before in an
area different to his domicile, which indicates that he
probably acquired the infection from contaminated
soils or organic matter, had a prolonged latency period,
and migrated to a non-endemic area, which finally
contributed to the presence of important sequelae.
There are several presentation forms from localized
and benign to disseminated, severe and progressive,
with important sequelae and poor prognosis. The clinical
course may be acute or sub-acute in young individuals
and chronic in adults. The most frequent classification
used, established in the International Symposium on
Paracoccidioidomycosis in Medellin, Colombia in 1986,
is based on the clinical correlation and the disease’s
natural history and comprises: paracoccidioidomycosis
infection, paracoccidioidomycosis disease, which
includes acute/sub-acute form (juvenile type) that can
be moderate or severe; chronic form (adult type) that
can be unifocal (slight, moderate, and severe), multifocal
(slight, moderate, and severe), and residual paracocci-
dioidomycosis8.
The acute/sub-acute form affects children,
adolescents, and young adults; it is present in individuals
up to 35 years of age, and has a short incubation period.
The chronic form is the most frequent clinical
presentation, usually affecting adult patients between
30 and 60 years of age. It is denominated unifocal when
only one organ is affected, it generally affects more
than one organ simultaneously (multifocal).
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In 51 to 100% of the patients there is pulmonary
affection with spotted bilateral infiltrate and hilar
adenopathy; the progressive forms affect mostly the
lower lobes and, in late stages, there is interstitial
fibrosis. The oropharyngeal mucosa is affected in 51 to
82% of the cases, presenting increased volume,
deformation, nodules and ulcerations that converge to
form plaques1,2. These lesions may appear in the soft
palate, gums, cheeks, floor of the mouth, tongue, and
lips -constituting moriform stomatitis. Generally, the
teeth become lose and some are lost; there is pain upon
chewing and swallowing, which impedes ingestion and
may lead to cachexia and death. Occasionally, there
may be limitation to opening the mouth due to fibrosis.
Because of the striking aspect of the central facial
lesions, these have been denominated «tapir mouth».
By extension, the pharynx, larynx, and trachea may be
affected, even causing destruction of the epiglottis and
the soft palate1,2.
The cutaneous areas affected tend to be the perioral
and nasal regions; showing nodular and ulcerated,
vegetative or verrucous, lesions of slow evolution and
few symptoms. In case of nodal compromise, it is
mainly noted in the cervical, inguinal, and supra-
clavicular regions.
Our patient presented pulmonary, cutaneous, and
oropharyngeal mucosa compromise with a «tapir mouth»
aspect, corresponding to a multifocal chronic case. The
diagnosis was done by isolating and identifying the
fungus via mycological exam through direct
examination, culture, histopathology, and serological
tests. Multiple budding with boat rudder aspect is
pathognomonic of P. brasiliensis. The main culture
media are Sabouraud agar and blood agar1,2,8.
The initial approach of patients with paracocci-
dioidomycosis constitutes a complete clinical evaluation
with laboratory studies and X-rays to determine the
degree of intensity and extension. The serological tests
are diagnostic tools and help to evaluate the therapeutic
response during follow up. This mycosis constitutes a
diagnostic and therapeutic challenge because of the
polymorphism of the lesions, chronicity, high costs,
and lack of consensus on the treatment of choice, which
include sulfonamides, amphotericin B, and imidazole
derivatives like itraconazole and ketoconazole9.
We are presenting a case of multifocal chronic
paracoccidioidomycosis in an adult, in an immuno-
competent patient residing in an urban zone without
apparent risk factors for acquiring the infection;
however, with the antecedent of having resided in rural
areas and performing agricultural tasks some years ago.
The characteristics of our case highlight the importance
of investigating the epidemiological antecedents in
cases of polymorphous cutaneous manifestations to
avoid delay in diagnosis and diminish possible sequelae
that will impact directly on the patient’s quality of life.
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